Hepatic Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elysium Health™ Announces Positive Results on Its Product Basis™ Published in Hepatology

/PRNewswire/ Elysium Health, Inc.™, a leading life sciences company focused on aging research, today announced that the detailed results from its clinical.

United statesLeonard guarenteStephen harrisonDariush mozaffarianTufts school of medicineTufts friedman school of nutrition sciencePrnewswire elysium health incElysium health scientific advisory boardBiology of aging researchPinnacle clinical researchGlenn centerElysium healthReduces markersHepatic inflammationNon alcoholic fatty liver diseasePinnacle clinical

Coya Therapeutics, Inc Announces Peer-Reviewed Publication of Phase 2a Clinical Trial Data for COYA 101 in Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, Inc Announces Peer-Reviewed Publication of Phase 2a Clinical Trial Data for COYA 101 in Amyotrophic Lateral Sclerosis (ALS)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactsinvestor contactdavid snyderStanleyh appelHoward bermanAdrian hepnerNeuroimmunology neuroinflammationContactjessica starmanCoya therapeutics incRegulatoryt lymphocyteBiologically activeOne yearAmyotrophic lateralHouston methodist hospitalChief executive officerChief medical officerScientific advisory board

Coya Therapeutics Secures Option Agreement for Exclusive

Proprietary technology generates Exosome Polymer Hybrids (EPHs) which allow for efficient and versatile method of customizing cargoes of Treg-derived.

United statesDavid snyderHoward bermanAdrian hepnerPhil campbellSubha dasCarnegie mellonCarnegie mellon universityCoya therapeutics incExosome polymer hybridsChief medical officerCoya therapeuticsSystemic lupus erythematosusHepatic inflammation